Experimental research has shown that mice lacking FGF23 exhibit hyperphosphatemia, hypercalcemia, ectopic calcification, and osteoporosis, whereas mice overexpressing FGF23 exhibit hypophosphatemia, rickets, and osteomalacia15. Here, FGF23 is linked to osteoporosis.